Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
Status:
Completed
Trial end date:
2020-08-05
Target enrollment:
Participant gender:
Summary
This is a Phase 2 randomized, double-blind, placebo-controlled, multi-center study to assess
the efficacy, safety, and pharmacokinetics of KBP-5074 in patients with moderate-to-severe
chronic kidney disease and uncontrolled hypertension.